These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10429516)

  • 1. [Trends in the treatment of cystic fibrosis].
    Rossi G
    Recenti Prog Med; 1999; 90(7-8):380-2. PubMed ID: 10429516
    [No Abstract]   [Full Text] [Related]  

  • 2. [New therapeutic approaches in cystic fibrosis].
    Vestner A; Schrepfer B; Kockler J; Mohr F; Zündorf I; Dingermann T
    Pharm Unserer Zeit; 2008; 37(5):354-5. PubMed ID: 18729285
    [No Abstract]   [Full Text] [Related]  

  • 3. Modulation of deltaF508 cystic fibrosis transmembrane regulator trafficking and function with 4-phenylbutyrate and flavonoids.
    Lim M; McKenzie K; Floyd AD; Kwon E; Zeitlin PL
    Am J Respir Cell Mol Biol; 2004 Sep; 31(3):351-7. PubMed ID: 15191910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase 1 study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung.
    Crystal RG; Jaffe A; Brody S; Mastrangeli A; McElvaney NG; Rosenfeld M; Chu CS; Danel C; Hay J; Eissa T
    Hum Gene Ther; 1995 May; 6(5):643-66. PubMed ID: 7578401
    [No Abstract]   [Full Text] [Related]  

  • 5. Cystic fibrosis gene therapy: the first trial.
    Arch Dis Child; 2015 Sep; 100(9):844. PubMed ID: 26205882
    [No Abstract]   [Full Text] [Related]  

  • 6. Cystic fibrosis: CFTR modulators and their mechanism of action.
    Nieddu E
    Curr Pharm Des; 2013; 19(19):3474-5. PubMed ID: 23331031
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cystic fibrosis].
    Yoshimura K; Tada H; Anzai C
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):606-11. PubMed ID: 9645146
    [No Abstract]   [Full Text] [Related]  

  • 8. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
    Perry LA; Penny-Dimri JC; Aslam AA; Lee TW; Southern KW
    Paediatr Respir Rev; 2017 Mar; 22():47-49. PubMed ID: 27964951
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of repeat administration of a replication deficient, recombinant adenovirus containing the normal cystic fibrosis transmembrane conductance regulator cDNA to the airways of individuals with cystic fibrosis.
    Crystal RG; Mastrangeli A; Sanders A; Cooke J; King T; Gilbert F; Henschke C; Pascal W; Herena J; Harvey BG
    Hum Gene Ther; 1995 May; 6(5):667-703. PubMed ID: 7578402
    [No Abstract]   [Full Text] [Related]  

  • 10. Status of gene therapy for cystic fibrosis lung disease.
    Boucher RC
    J Clin Invest; 1999 Feb; 103(4):441-5. PubMed ID: 10021450
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy.
    Kerem E
    Pediatr Pulmonol; 2005 Sep; 40(3):183-96. PubMed ID: 15880796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic testing to provide targeted treatment for cystic fibrosis patients.
    Edelman A; Sermet-Gaudelus I; Rousset JP
    Pharmacogenomics; 2007 Sep; 8(9):1101-4. PubMed ID: 17924824
    [No Abstract]   [Full Text] [Related]  

  • 13. [Protein repair therapy in cystic fibrosis].
    Clément A; Tamalet A; Fauroux B; Epaud R
    Rev Prat; 2003 Jan; 53(2):163-6. PubMed ID: 12664848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges facing microRNA therapeutics for cystic fibrosis lung disease.
    De Santi C; Greene CM
    Epigenomics; 2020 Feb; 12(3):179-181. PubMed ID: 32011168
    [No Abstract]   [Full Text] [Related]  

  • 15. New approaches to cystic fibrosis.
    Moss RB
    Hosp Pract (1995); 2001 Jan; 36(1):25-7, 31-2, 35-7. PubMed ID: 11197941
    [No Abstract]   [Full Text] [Related]  

  • 16. In utero efficacy of cystic fibrosis gene therapy: difficult studies, positive or negative.
    Flotte TR
    Mol Ther; 2008 May; 16(5):806-7. PubMed ID: 18432269
    [No Abstract]   [Full Text] [Related]  

  • 17. Towards the pharmacogenomics of cystic fibrosis.
    Sangiuolo F; D'Apice MR; Bruscia E; Lucidi V; Novelli G
    Pharmacogenomics; 2002 Jan; 3(1):75-87. PubMed ID: 11966405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current progress in cystic fibrosis: is this a disease elusive to therapy?
    Brown C
    Pulm Pharmacol Ther; 2008 Aug; 21(4):585-7. PubMed ID: 18313958
    [No Abstract]   [Full Text] [Related]  

  • 19. Gene therapy for cystic fibrosis.
    Alton E; Smith S; Geddes D
    Lancet; 1997 Apr; 349(9060):1249-50. PubMed ID: 9130964
    [No Abstract]   [Full Text] [Related]  

  • 20. Gene therapy in cystic fibrosis.
    Prickett M; Jain M
    Transl Res; 2013 Apr; 161(4):255-64. PubMed ID: 23273902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.